Smartleaf Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
21,744
-1,571
-7% -$126K 0.05% 333
2025
Q4
$2.24M Sell
23,315
-264
-1% -$25.9K 0.08% 209
2025
Q3
$2.29M Buy
23,579
+6,049
+35% +$626K 0.14% 154
2025
Q2
$1.87M Sell
17,530
-2,365
-12% -$239K 0.16% 131
2025
Q1
$1.98M Buy
19,895
+1,162
+6% +$117K 0.19% 119
2024
Q4
$1.68M Buy
18,733
+3,710
+25% +$327K 0.17% 136
2024
Q3
$1.25M Buy
15,023
+3,162
+27% +$249K 0.15% 151
2024
Q2
$913K Buy
11,861
+2,178
+22% +$159K 0.15% 157
2024
Q1
$664K Buy
9,683
+2,648
+38% +$170K 0.13% 185
2023
Q4
$390K Buy
+7,035
New +$376K 0.1% 197

Other funds holding BSX

Smartleaf Asset Management's BSX Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Boston Scientific (BSX) stake by 6.7% in Q1 2026, selling an estimated $126K and leaving 21,744 shares worth $1.37M. The position accounts for 0.05% of the portfolio, ranked #333.

Smartleaf Asset Management first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.29M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Smartleaf Asset Management held 21,744 shares of Boston Scientific worth $1.37M as of Q1 2026.
  • Smartleaf Asset Management sold 1,571 Boston Scientific shares in Q1 2026, an estimated $126K.
  • Boston Scientific made up 0.05% of Smartleaf Asset Management's portfolio in Q1 2026, its #333 holding.
  • Smartleaf Asset Management first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Boston Scientific position peaked at $2.29M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.